COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 882: Articles 8811-8820  | Next

Narratives of the convalescent plasma donor in a Peruvian social security hospital: motivations, fears, expectations and experiences
Matassini Eyzaguirre, S. M., Villanueva Yapa, C., Chunga Chunga, A., Sagastegui Soto, A., Neyra Vera, I. M., Soto-Ordonez, S., Guillermo Roman, M., Oyanguren Miranda, M., Soto-Becerra, P., Hurtado-Roca, Y., Maguina, J. L., Araujo-Castillo, R. V.
10.1101/2022.02.16.22270690 — Posted: 2022-02-19
Should COVID-specific arrangements for abortion continue? The views of women experiencing abortion in Britain during the pandemic.
Lohr, P., Lewandowska, M., Meiksin, R., Scott, R., Reiter, J., Salaria, N., Cameron, S., Palmer, M., French, R., Wellings, K., SACHA Study
10.1101/2022.02.17.22271080 — Posted: 2022-02-19
The effects of COVID-19 on European healthcare provision for people with major depressive disorder: a scoping review protocol
Sually, D., Wong, W. L. E., Hidalgo-Mazzei, D., Quoidbach, V., Simon, J., Boyer, P., Strawbridge, R., Young, A. H.
10.1101/2022.02.17.22269638 — Posted: 2022-02-19
Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19
Uckun, F., Saeed, M., Awili, M., Ozercan, I., Qazi, S., Lee, C., Shibli, A., Skolnick, A., Prusmack, A., Varon, J., Barrera, C., Orhan, C., Volk, M., Sahin, K.
10.1101/2022.02.12.22270748 — Posted: 2022-02-18
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chen, C., Martinez, D. R., Marti, M. M., Schaefer, A., Cheng, M. H., Mannar, D., Zhu, X., Berezuk, A. M., Banerjee, A., Sobolewski, M. D., Kim, A., Treat, B. R., Da Silva Castanha, P. M., Enick, N., McCormick, K. D., Liu, X., Adams, C., Hines, M. G., Sun, Z., Chen, W., Jacobs, J. L., Barratt-Boyes, S. M., Mellors, J. W., Baric, R. S., Bahar, I., Dimitrov, D. S., Subramaniam, S., Saville, J. W., Li, W.
10.1101/2022.02.18.481058 — Posted: 2022-02-18
Furin-cleavage site is present in an antiparallel β-strand in SARS-CoV2 Spike protein
Bashir, A.
10.1101/2022.02.18.481028 — Posted: 2022-02-18
Mosaic receptor-binding domain nanoparticles induce protective immunity against SARS-CoV-2 challenges
Lee, D. B., Kim, H., Jeong, J. H., Jang, E. s., Chang, Y. Y., Roh, S., Jeon, H., Kim, E. J., Han, S. Y., Maeng, J. Y., Magez, S., Radwanska, M., Mun, J. Y., Jun, H. S., Lee, G., Song, M.-S., Lee, H.-R., Chung, M. S., Baek, Y. H., Kim, K. H.
10.1101/2022.02.18.480994 — Posted: 2022-02-18
Genomic Characterization of Sars-Cov-2 from Islamabad Pakistan by Rapid Nanopore Sequencing
Badar, N., Ikram, A., Salman, M., Umair, M., Rehman, Z., Ahad, A., Mirza, H. a., Alam, M., Mehmood, N., aamir, U. B.
10.1101/2022.02.17.480826 — Posted: 2022-02-18
Metagenomic analysis reveals the abundance and diversity of opportunistic fungal pathogens in the nasopharyngeal tract of COVID-19 patients
Hoque, M. N., Rahman, M. S., Sarkar, M. M. H., Habib, M. A., Hossain, M. A., Khan, M. S., Islam, T.
10.1101/2022.02.17.480819 — Posted: 2022-02-18
SARS-CoV-2 has not emerged in roe, red or fallow deer in Germany or Austria during the COVID 19 pandemic
Moreira-Soto, A., Walzer, C., Czirjak, G. A., Richter, M., Marino, S. F., Posautz, A., Rodo de Yebra, P., McEwen, G. K., Drexler, J. F., Greenwood, A. D.
10.1101/2022.02.18.480872 — Posted: 2022-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).